Article Versions Notes

Fröhlich E, Bordoni A, Mohsenzada N, Mitsche S, Schröttner H, Zellnitz-Neugebauer S. Development of Co-Amorphous Systems for Inhalation Therapy—Part 1: From Model Prediction to Clinical Success. Pharmaceutics. 2025; 17(7):922. https://doi.org/10.3390/pharmaceutics17070922

Fröhlich, Eleonore, Aurora Bordoni, Nila Mohsenzada, Stefan Mitsche, Hartmuth Schröttner, and Sarah Zellnitz-Neugebauer. 2025. "Development of Co-Amorphous Systems for Inhalation Therapy—Part 1: From Model Prediction to Clinical Success" Pharmaceutics 17, no. 7: 922. https://doi.org/10.3390/pharmaceutics17070922

Fröhlich, E., Bordoni, A., Mohsenzada, N., Mitsche, S., Schröttner, H., & Zellnitz-Neugebauer, S. (2025). Development of Co-Amorphous Systems for Inhalation Therapy—Part 1: From Model Prediction to Clinical Success. Pharmaceutics, 17(7), 922. https://doi.org/10.3390/pharmaceutics17070922